98 related articles for article (PubMed ID: 24841500)
1. Collagen triple helix repeat containing 1 is overexpressed in hepatocellular carcinoma and promotes cell proliferation and motility.
Tameda M; Sugimoto K; Shiraki K; Yamamoto N; Okamoto R; Usui M; Ito M; Takei Y; Nobori T; Kojima T; Suzuki H; Uchida M; Uchida K
Int J Oncol; 2014 Aug; 45(2):541-8. PubMed ID: 24841500
[TBL] [Abstract][Full Text] [Related]
2. Fatty acid-CoA ligase 4 is overexpressed in human hepatocellular carcinoma.
Sung YK; Hwang SY; Park MK; Bae HI; Kim WH; Kim JC; Kim M
Cancer Sci; 2003 May; 94(5):421-4. PubMed ID: 12824887
[TBL] [Abstract][Full Text] [Related]
3. The role of collagen triple helix repeat containing 1 (CTHRC1) in cancer development and progression.
Singh CK; Fernandez S; Chhabra G; Zaemisch GR; Nihal A; Swanlund J; Ansari N; Said Z; Chang H; Ahmad N
Expert Opin Ther Targets; 2024 May; 28(5):419-435. PubMed ID: 38686865
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of collagen triple helix repeat containing 1 (CTHRC1) is associated with tumour aggressiveness and poor prognosis in human non-small cell lung cancer.
Ke Z; He W; Lai Y; Guo X; Chen S; Li S; Wang Y; Wang L
Oncotarget; 2014 Oct; 5(19):9410-24. PubMed ID: 25238260
[TBL] [Abstract][Full Text] [Related]
5. The collagen triple helix repeat containing 1 facilitates hepatitis B virus-associated hepatocellular carcinoma progression by regulating multiple cellular factors and signal cascades.
Zhang R; Cao Y; Bai L; Zhu C; Li R; He H; Liu Y; Wu K; Liu F; Wu J
Mol Carcinog; 2015 Dec; 54(12):1554-66. PubMed ID: 25263696
[TBL] [Abstract][Full Text] [Related]
6. CTHRC1 induces non-small cell lung cancer (NSCLC) invasion through upregulating MMP-7/MMP-9.
He W; Zhang H; Wang Y; Zhou Y; Luo Y; Cui Y; Jiang N; Jiang W; Wang H; Xu D; Li S; Wang Z; Chen Y; Sun Y; Zhang Y; Tseng HR; Zou X; Wang L; Ke Z
BMC Cancer; 2018 Apr; 18(1):400. PubMed ID: 29631554
[TBL] [Abstract][Full Text] [Related]
7. CTHRC1 mediates IL‑1β‑induced apoptosis in chondrocytes via JNK1/2 signaling.
Zhang Q; Yin ZS; Zhang FW; Cao K; Sun HY
Int J Mol Med; 2018 Apr; 41(4):2270-2278. PubMed ID: 29393342
[TBL] [Abstract][Full Text] [Related]
8. Collagen triple helix repeat containing 1 (CTHRC1) activates Integrin β3/FAK signaling and promotes metastasis in ovarian cancer.
Guo B; Yan H; Li L; Yin K; Ji F; Zhang S
J Ovarian Res; 2017 Oct; 10(1):69. PubMed ID: 29021002
[TBL] [Abstract][Full Text] [Related]
9. Collagen triple helix repeat containing-1 negatively regulated by microRNA-30c promotes cell proliferation and metastasis and indicates poor prognosis in breast cancer.
Lai YH; Chen J; Wang XP; Wu YQ; Peng HT; Lin XH; Wang WJ
J Exp Clin Cancer Res; 2017 Jul; 36(1):92. PubMed ID: 28697793
[TBL] [Abstract][Full Text] [Related]
10. High expression of Collagen Triple Helix Repeat Containing 1 (CTHRC1) facilitates progression of oesophageal squamous cell carcinoma through MAPK/MEK/ERK/FRA-1 activation.
Wang C; Li Z; Shao F; Yang X; Feng X; Shi S; Gao Y; He J
J Exp Clin Cancer Res; 2017 Jun; 36(1):84. PubMed ID: 28645305
[TBL] [Abstract][Full Text] [Related]
11. E6/E7-P53-POU2F1-CTHRC1 axis promotes cervical cancer metastasis and activates Wnt/PCP pathway.
Zhang R; Lu H; Lyu YY; Yang XM; Zhu LY; Yang GD; Jiang PC; Re Y; Song WW; Wang JH; Zhang CC; Gu F; Luo TJ; Wu ZY; Xu CJ
Sci Rep; 2017 Mar; 7():44744. PubMed ID: 28303973
[TBL] [Abstract][Full Text] [Related]
12. Upregulated CTHRC1 promotes human epithelial ovarian cancer invasion through activating EGFR signaling.
Ye J; Chen W; Wu ZY; Zhang JH; Fei H; Zhang LW; Wang YH; Chen YP; Yang XM
Oncol Rep; 2016 Dec; 36(6):3588-3596. PubMed ID: 27779718
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of CTHRC1 protein expression in human cancers: a meta-analysis.
Wang SF; Yin Z; Yin JJ; Zhang W; Dong CG
Genet Mol Res; 2016 May; 15(2):. PubMed ID: 27323076
[TBL] [Abstract][Full Text] [Related]
14. Preliminary observations regarding the expression of collagen triple helix repeat-containing 1 is an independent prognostic factor for Wilms' tumor.
Qi C; Hu Y; Yang F; An H; Zhang J; Jin H; Guo F
J Pediatr Surg; 2016 Sep; 51(9):1501-6. PubMed ID: 27230801
[TBL] [Abstract][Full Text] [Related]
15. Lentivirus-Mediated Knockdown of CTHRC1 Inhibits Osteosarcoma Cell Proliferation and Migration.
Sang W; Zhu L; Ma J; Lu H; Wang C
Cancer Biother Radiopharm; 2016 Apr; 31(3):91-8. PubMed ID: 27043295
[TBL] [Abstract][Full Text] [Related]
16. High expression of CTHRC1 promotes EMT of epithelial ovarian cancer (EOC) and is associated with poor prognosis.
Hou M; Cheng Z; Shen H; He S; Li Y; Pan Y; Feng C; Chen X; Zhang Y; Lin M; Wang L; Ke Z
Oncotarget; 2015 Nov; 6(34):35813-29. PubMed ID: 26452130
[TBL] [Abstract][Full Text] [Related]
17. Elevated plasma levels of the pituitary hormone Cthrc1 in individuals with red hair but not in patients with solid tumors.
Duarte CW; Stohn JP; Wang Q; Emery IF; Prueser A; Lindner V
PLoS One; 2014; 9(6):e100449. PubMed ID: 24945147
[TBL] [Abstract][Full Text] [Related]
18. CTHRC1 Induces Pancreatic Stellate Cells (PSCs) into Myofibroblast-like Cancer-Associated Fibroblasts (myCAFs).
Kang MK; Jiang F; Kim YJ; Ryu K; Masamune A; Hamada S; Park YY; Koh SS
Cancers (Basel); 2023 Jun; 15(13):. PubMed ID: 37444482
[No Abstract] [Full Text] [Related]
19. CTHRC1, a novel gene with multiple functions in physiology, disease and solid tumors (Review).
Liu YJ; Du J; Li J; Tan XP; Zhang Q
Oncol Lett; 2023 Jun; 25(6):266. PubMed ID: 37216164
[TBL] [Abstract][Full Text] [Related]
20. Identification of multi-omics biomarkers and construction of the novel prognostic model for hepatocellular carcinoma.
Liu X; Xiao C; Yue K; Chen M; Zhou H; Yan X
Sci Rep; 2022 Jul; 12(1):12084. PubMed ID: 35840618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
